Viewing Study NCT00182702


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-06-06 @ 5:27 PM
Study NCT ID: NCT00182702
Status: COMPLETED
Last Update Posted: 2013-03-25
First Post: 2005-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear Cell Renal Cell Carcinoma View
None Recurrent Renal Cell Cancer View
None Stage III Renal Cell Cancer View
None Stage IV Renal Cell Cancer View
Keywords: